Adaptation and Evaluation of Bright Horizons
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Feb 15, 2023
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called "Bright Horizons," which aims to help adolescents reduce binge drinking and substance use. The program was created by the White Mountain Apache Tribe and Johns Hopkins University and focuses on teaching young people how to manage their emotions, cope with challenges, and solve problems. It also encourages setting personal goals to help them connect with treatment options and make healthier choices.
To be eligible for this study, participants must be between the ages of 12 and 17, have experienced binge drinking recently, identify as Native American, and live near the Fort Apache Indian Reservation. They will need permission from a parent or guardian to participate. Participants will engage in the Bright Horizons program, which is designed to be supportive and educational. It’s important to note that individuals with severe medical or mental health issues, recent traumatic experiences, or language barriers may not qualify for this trial. This study is not yet recruiting participants, but it aims to provide valuable insights into how to support youth in overcoming substance use challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 12-17
- • Confirmed binge alcohol use event reported to the surveillance system within 90 days
- • Self identify as Native American
- • Reside on or near the Fort Apache Indian Reservation
- • Have parental or legal guardian consent/provide youth assent
- Exclusion Criteria:
- • Unstable and severe medical, psychiatric or drug use problems that necessitates inpatient treatment
- • Acute suicidal or homicidal ideation requiring immediate intervention
- • Recent and severe stressful life events such as physical or sexual abuse, or violent crime victimization that requires specific and high intensity interventions or out of home placement
- • Doesn't speak English
- • Severally visually impaired
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Whiteriver, Arizona, United States
Patients applied
Trial Officials
Mary Cwik, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials